Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-13,183
Closed -$3.85M 456
2015
Q3
$3.85M Buy
13,183
+3,788
+40% +$1.25M 0.51% 2
2015
Q2
$3.79M Buy
+9,395
New +$3.77M 0.52% 1
2015
Q1
Sell
-11,932
Closed -$4.05M 509
2014
Q4
$4.05M Buy
+11,932
New +$3.86M 0.51% 5
2014
Q3
Sell
-10,490
Closed -$3.31M 508
2014
Q2
$3.31M Buy
+10,490
New +$3.16M 0.49% 43
2014
Q1
Sell
-10,872
Closed -$3.04M 471
2013
Q4
$3.04M Buy
10,872
+103
+1% +$26.6K 0.5% 48
2013
Q3
$2.59M Buy
+10,769
New +$2.41M 0.5% 52

Other funds holding BIIB

Santa Fe Partners's BIIB Position: Q4 2015 in Review

Santa Fe Partners sold out of Biogen (BIIB) in Q4 2015, closing a stake of 13,183 shares — an estimated $3.85M sold.

Santa Fe Partners first reported a position in BIIB in Q3 2013 and held it in 6 quarters. The position peaked at $4.05M in Q4 2014. 969 funds tracked by Wall St. Rank hold BIIB as of Q4 2015.

  • Santa Fe Partners reported no remaining Biogen position as of Q4 2015 after selling out during the quarter.
  • Santa Fe Partners sold 13,183 Biogen shares in Q4 2015, an estimated $3.85M.
  • Santa Fe Partners first reported a position in Biogen in Q3 2013 and held it in 6 quarters.
  • Santa Fe Partners's Biogen position peaked at $4.05M in Q4 2014.
  • 969 funds tracked by Wall St. Rank held Biogen as of Q4 2015.

Based on Santa Fe Partners's 13F filing for Q4 2015, filed 12 Feb 2016.